ZSB Stock Overview
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Sirona Biochem Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.04 |
52 Week High | CA$0.13 |
52 Week Low | CA$0.039 |
Beta | -0.44 |
1 Month Change | -19.03% |
3 Month Change | -45.50% |
1 Year Change | -40.12% |
3 Year Change | -82.61% |
5 Year Change | -69.23% |
Change since IPO | -27.27% |
Recent News & Updates
Recent updates
Shareholder Returns
ZSB | DE Biotechs | DE Market | |
---|---|---|---|
7D | 0% | -1.7% | -1.7% |
1Y | -40.1% | -15.7% | 1.4% |
Return vs Industry: ZSB underperformed the German Biotechs industry which returned -15.7% over the past year.
Return vs Market: ZSB underperformed the German Market which returned 1.4% over the past year.
Price Volatility
ZSB volatility | |
---|---|
ZSB Average Weekly Movement | 21.3% |
Biotechs Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 9.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ZSB's share price has been volatile over the past 3 months.
Volatility Over Time: ZSB's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | Howard Verrico | www.sironabiochem.com |
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009.
Sirona Biochem Corp. Fundamentals Summary
ZSB fundamental statistics | |
---|---|
Market cap | €11.37m |
Earnings (TTM) | -€1.81m |
Revenue (TTM) | €24.79k |
458.6x
P/S Ratio-6.3x
P/E RatioIs ZSB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZSB income statement (TTM) | |
---|---|
Revenue | CA$36.35k |
Cost of Revenue | CA$63.45k |
Gross Profit | -CA$27.09k |
Other Expenses | CA$2.63m |
Earnings | -CA$2.65m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.01 |
Gross Margin | -74.54% |
Net Profit Margin | -7,297.87% |
Debt/Equity Ratio | -84.1% |
How did ZSB perform over the long term?
See historical performance and comparison